Study Supports Antibody Testing in Obstetrical Lupus Treatment
A new study entitled Obstetric antiphospholipid syndrome (OAPS) explores the connection between antiphospholipid antibodies (aPL) in pregnant women with lupus. aPL-positive women are at a higher risk of pregnancy complications when also diagnosed with lupus. Approximately, 30-40% of women with lupus are positive for at least one aPL, and the frequency of aPL positivity varies with ethnicity. For mom’s health and baby’s, the study suggests all patients with lupus be tested for aPL at diagnosis and again before planned pregnancies so that the best prophylactic treatments can be given. Information about antiphospholipid antibody syndrome, and pregnancy and the syndrome is available at lupus.org.